弥漫性子宫腺肌病保留生育功能手术:Osada术式的分步讲解
本文以分步视频演示方式介绍日本Hisao Osada医生2011年开发的腹腔镜辅助开腹Osada术式,用于弥漫性子宫腺肌病的保留生育功能切除。患者37岁未产女性,切除腺肌病组织469 g,术后第2天出院无并发症,3个月后症状、子宫血流、宫腔通畅性及子宫尺寸(由19×10 cm恢复至11×7 cm)均改善。
要点
- Osada术式采用8个离散手术步骤,包括预防性止血技术与三瓣法子宫壁重建。
- 患者术中失血少,切除腺肌病组织469 g,术后第2天出院,无并发症。
- 多数文献支持术后等待至少6-12个月且术区子宫血流恢复正常后再尝试受孕。
核心结论
- 遵循视频演示的8个离散步骤,使用Osada术式可安全实现弥漫性子宫腺肌病的保留生育功能切除。
- 生殖外科医生可参考该视频学习并维持这一重要手术。
研究设计与样本
- 设计为带解说视频的Osada术式分步演示。
- 患者为37岁未产女性,有盆腔痛、腹部包块症状、异常子宫出血及不孕。
- 体格检查示20周大小 bulky 子宫,双合诊活动度受限;因解剖扭曲明显宫腔无法探入。
- 磁共振成像示15 cm腺肌瘤伴后子宫腔室弥漫性腺肌病组织致内膜轮廓明显异常。
- 既往干预包括联合激素避孕药、醋酸亮丙瑞林及氨甲环酸。
主要发现
- 围术期失血少,切除腺肌病组织469 g,术后第2天出院,无并发症。
- 3个月后周期性疼痛及出血明显改善。
- 超声确认全子宫多普勒血流;子宫输卵管造影示宫腔未闭塞且输卵管通畅。
- 磁共振成像确认子宫尺寸由19×10 cm恢复至11×7 cm。
- 与其他弥漫性子宫腺肌病切除方法相比,Osada术式报告的产科结局最佳。
关键数值与推荐
- Osada术式包括8个手术步骤,并术中全身给予氨甲环酸。
- 多数文献支持等待至少6-12个月且术区子宫血流恢复正常后再尝试受孕。
临床怎么用
- 生殖外科医生可参考本视频学习并维持Osada术式。
- 多数文献支持术后等待至少6-12个月且术区子宫血流恢复正常后再尝试受孕。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To equip reproductive surgeons with an approach to the Osada procedure and critical prophylactic hemostatic measures that optimize perioperative outcomes. DESIGN: Stepwise demonstration of the Osada procedure with narrated video footage. SETTING: Definitive management of symptomatic adenomyosis requires hysterectomy. However, adenomyomectomy can improve symptoms and restore anatomy while maintaining fertility potential. Limited but comparable perioperative outcomes exist for minimally invasive methods of adenomyomectomy, and most involve resection of focal, not diffuse, adenomyosis. Among the literature involving resection of diffuse adenomyosis using minimally invasive methods, relatively small volumes of resected tissue are reported and none include obstetric outcomes. Most published reports for excision of diffuse adenomyosis involve laparotomic resection, likely because of specific intraoperative challenges curtailed by this approach. In response, a laparoscopic-assisted laparotomic approach was developed in 2011 by Dr. Hisao Osada, a reproductive surgeon in Japan. This procedure involves aggressive excision of adenomyotic tissue with prophylactic hemostatic techniques and subsequent uterine wall reconstruction using a triple-flap method. Compared with other excisional methods for diffuse adenomyomectomy, the Osada procedure has the best reported obstetric outcomes. PATIENT(S): A 37-year-old nulliparous female presented with pelvic pain, bulk symptoms, abnormal uterine bleeding, and infertility. Physical examination demonstrated a 20-week, bulky uterus with limited bimanual mobility. Her endometrial cavity was inaccessible because of marked anatomic distortion. Magnetic resonance imaging revealed marked abnormality of her endometrial contour because of a 15 cm adenomyoma with diffuse adenomyomatous tissue in the posterior uterine compartment. Prior interventions included a trial of combined hormonal contraceptive, leuprolide acetate, and tranexamic acid. She was interested in fertility-sparing adenomyomectomy to address symptoms and fertility potential and chose to proceed with the Osada procedure. She was optimized medically with oral and parenteral iron therapy to bring her hemoglobin from 55-111 g/L preoperatively. Institutional review board approval and informed consent from the patient were obtained. INTERVENTION(S): The Osada procedure was performed using the following 8 surgical steps: Systemic administration of tranexamic acid was also administered intraoperatively. MAIN OUTCOME MEASURE(S): Perioperative blood loss, anatomic normalization, symptom remediation, and maintenance of fertility potential. RESULTS: Perioperative blood loss was minimal, 469 g of adenomyotic tissue was extracted, and discharge was on postoperative day 2 without any complications. Three months later, cyclic pain and bleeding had improved markedly, ultrasound confirmed Doppler flow throughout the uterus, hysterosalpingogram demonstrated a nonobliterated endometrial cavity and tubal patency, and magnetic resonance imaging confirmed normalized uterine dimensions measuring 11 × 7 cm from 19 × 10 cm. Most literature supports waiting at least 6-12 months and until demonstration of normalized uterine blood flow in the operated area before attempting conception. CONCLUSION: Fertility-sparing excision of diffuse adenomyosis can be achieved safely using the Osada procedure, following the 8 discrete steps demonstrated in this video. Reproductive surgeons can reference this video to teach and maintain this important procedure.
引用
- Lu C, Corbett C, Elliott JE, et al. Fertility-sparing surgery for diffuse adenomyosis: a narrated, stepwise approach to the Osada procedure. Fertil Steril. 2022. PMID: 35961921. doi:10.1016/j.fertnstert.2022.06.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。